var data={"title":"Betaine (anhydrous, not equivalent to betaine hydrochloride): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Betaine (anhydrous, not equivalent to betaine hydrochloride): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5731?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-drug-information\" class=\"drug drug_general\">see &quot;Betaine (anhydrous, not equivalent to betaine hydrochloride): Drug information&quot;</a> and <a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-patient-drug-information\" class=\"drug drug_patient\">see &quot;Betaine (anhydrous, not equivalent to betaine hydrochloride): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140590\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Cystadane</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140591\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Cystadane</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1056826\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Homocystinuria, Treatment Agent</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13207398\" class=\"block don drugH1Div\"><span class=\"drugH1\">Dosing: Neonatal</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Homocystinuria</b>: <b>Note: </b>The overall role of betaine in management of homocystinuria and effectiveness is variable and dependent upon several factors, including specific enzyme deficiency, genetic mutation(s), and clinical condition; dose should be individualized.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Term neonate: Oral: 50 mg/kg/dose twice daily; increase at weekly intervals in 50 mg/kg/day increments; increase gradually until plasma total homocysteine is undetectable or present in small amounts (Al Tawari 2002; Diekman 2014; Schiff 2011). <b>Note:</b> Minimal additional benefit expected with doses &gt;150 to 200 mg/kg/day or exceeding a twice daily dosing schedule (Morris 2017); however, case reports in infants suggest more frequent dosing may be necessary in some patients (Schiff 2011; Ucar 2010).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1056822\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-drug-information\" class=\"drug drug_general\">see &quot;Betaine (anhydrous, not equivalent to betaine hydrochloride): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric: <b>Homocystinuria:</b> <b>Note: </b>The overall role of betaine in management of homocystinuria and effectiveness is variable and dependent upon several factors, including specific enzyme deficiency, genetic mutation(s), and clinical condition; dose should be individualized.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants and Children &lt;3 years: Oral: 50 mg/kg/dose twice daily; increase at weekly intervals in 50 mg/kg/day increments until plasma total homocysteine is undetectable or present in small amounts. <b>Note:</b> Minimal additional benefit has been observed with dosages &gt;150 to 200 mg/kg/day or exceeding a twice daily dosing schedule (Morris 2017); however, case reports in infants suggest more frequent dosing may be necessary in some patients (Schiff 2011; Ucar 2010).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &ge;3 years and Adolescents: Oral: 3,000 mg twice daily; increase gradually until plasma total homocysteine is undetectable or present in small amounts; in some patients, doses up to 20 g/day have been needed to control homocysteine plasma concentrations. <b>Note:</b> Minimal benefit has been observed with dosages &gt;20 g/day or exceeding a twice daily dosing schedule.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult: <b>Homocystinuria:</b> Oral: 3,000 mg twice daily. Dosages of up to 20 g/day have been necessary to control homocysteine levels in some patients.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140580\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Powder, Oral, as anhydrous: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cystadane: 1 g/scoop (180 g)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140570\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F11239625\" class=\"block accres drugH1Div\"><span class=\"drugH1\">Prescribing and Access Restrictions</span>\n    <p style=\"text-indent:0em;display:inline\">Cystadane may be obtained by contacting AnovoRx at wholesale@anovorx.com.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1056829\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Oral: Administer without regard to food immediately after reconstitution; do not use if powder does not completely dissolve or gives a colored solution.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2613425\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Store at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Protect from moisture</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1056828\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Treatment of homocystinuria to reduce elevated homocysteine blood concentrations (FDA approved in pediatric patients [age not specified] and adults); homocystinuria includes deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylenetetrahydrofolate reductase (MTHFR), and cobalamin cofactor metabolism (cbl)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140604\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Betaine anhydrous may be confused with betaine hydrochloride (a nutritional supplement)</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">Betaine may be confused with Betadine</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">Cystadane may be confused with cysteamine, cysteine</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140603\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Diarrhea, dysgeusia, gastrointestinal distress, nausea</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rare but important or life-threatening: Abnormal skin odor, agitation, alopecia, anorexia, cerebral edema (associated with hypermethioninemia), dental disease, depression, glossitis, irritability, personality disorder, sleep disorder, urinary incontinence, urticaria, vomiting</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140584\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">There are no contraindications listed in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2989268\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cystathionine beta-synthase (CBS) deficiency: Use caution in patients with CBS deficiency; treatment with betaine may cause large increases of plasma methionine concentrations which may cause cerebral edema.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>\n        <b>&#65279;Dosage form specific issues: </b></i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Betaine anhydrous, a prescription medication indicated for the treatment of homocystinuria and betaine hydrochloride, a nutritional supplement, are not to be used interchangeably (ISMP 2016).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13298857\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6218393\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=13041&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140577\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F140587\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1056825\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Variable based upon enzyme deficiency and genetic mutation; should include: Serum total homocysteine, methionine, and other amino acids as applicable; frequency varies based on clinical condition (Diekman 2011; Morris 2017)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F3343058\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Betaine is an endogenous metabolite of choline. Betaine acts as a methyl group donor in the remethylation of homocysteine to methionine. Homocystinuria is an inborn error of metabolism in which elevated plasma homocysteine levels can lead to mental retardation, ocular abnormalities, osteoporosis, premature atherosclerosis and thromboembolic disease. Remethylation is one of the two divergent pathways in the metabolism of homocysteine. The second pathway involves transulfuration of homocysteine to produce cysteine.  A number of enzymes and cofactors are also involved in these pathways. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1056832\" class=\"block adi drugH1Div\"><span class=\"drugH1\">Additional Information</span>\n    <p style=\"text-indent:0em;display:inline\">Vitamin B<sub>6</sub>, vitamin B<sub>12</sub>, and folate have been helpful in the management of homocystinuria and are often used in conjunction.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6038539\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Cystadan (AU, IL);</li>\n      <li>Cystadane (BB, CZ, DK, EE, HU, IS, JP, KR, LT, LV, MT, NO, PL, SE, SI, SK);</li>\n      <li>Reqmed (JP)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Acute Care ISMP Medication Safety Alert! http://www.ismp.org/newsletters/acutecare/issue.aspx?id=1139. Published December 1, 2016. Accessed March 8, 2018.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Al Tawari AA, Ramadan DG, Neubauer D, Heberle LC, Al Awadi F. An early onset form of methylenetetrahydrofolate reductase deficiency: a report of a family from Kuwait. <i>Brain Dev</i>. 2002;24(5):304-309.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/12142069/pubmed\" target=\"_blank\" id=\"12142069\">12142069</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Burns SP, Iles RA, Ryalls M, et al &ldquo;Methylgenesis From Betaine in Cystathionine-Beta-Synthase Deficiency,&rdquo; <i>Biochem Soc Trans</i>, 1993, 21:455S.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/ 7510653 /pubmed\" target=\"_blank\" id=\" 7510653 \"> 7510653 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cystadane (betaine anhydrous) [prescribing information]. Memphis, TN: AnovoRx Distribution, LLC; April 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Devlin AM, Hajipour L, Gholkar A, &ldquo;Cerebral Edema Associated With Betaine Treatment in Classical Homocystinuria,&rdquo; <i>J Pediatr</i>, 2001,144(4):545-8.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Diekman EF, de Koning TJ, Verhoeven-Duif NM, Rovers MM, van Hasselt PM. Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency. <i>JAMA Neurol</i>. 2014;71(2):188-194.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/24323041/pubmed\" target=\"_blank\" id=\"24323041\">24323041</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kishi T, Kawamura I, Harada Y, et al, &ldquo;Effect of Betaine on S-Adenosylmethionine Levels in the Cerebrospinal Fluid in a Patient With Methylenetetrahydrofolate Reductase Deficiency and Peripheral Neuropathy,&rdquo; <i>J Inherit Metab Dis</i>, 1994, 17(5):560-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/7837762/pubmed\" target=\"_blank\" id=\"7837762\">7837762</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lawson-Yuen A and Levy, HL, &ldquo;The Use of Betaine in the Treatment of Elevated Homocysteine,&rdquo; <i>Mol Genet Metab</i>, 2006, 88(3):201-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/16545978/pubmed\" target=\"_blank\" id=\"16545978\">16545978</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Matthews A, Johnson TN, Rostami-Hodjegan A, et al, &ldquo;An Indirect Response Model of Homocysteine Suppression by Betaine: Optimising the Dosage Regimen of Betaine in Homocystinuria,&rdquo; <i>Br J Clin Pharmacol</i>, 2002, 54(2):140-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/ 12207633 /pubmed\" target=\"_blank\" id=\" 12207633 \"> 12207633 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Morris AA, Ko&#382;ich V, Santra S, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. <i>J Inherit Metab Dis</i>. 2017;40(1):49-74.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/27778219/pubmed\" target=\"_blank\" id=\"27778219\">27778219</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Schiff M, Benoist JF, Tilea B, Royer N, Giraudier S, Ogier de Baulny H. Isolated remethylation disorders: do our treatments benefit patients? <i>J Inherit Metab Dis</i>. 2011;34(1):137-145.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/20490923/pubmed\" target=\"_blank\" id=\"20490923\">20490923</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Schiff M, Benoist JF, Tilea B, Royer N, Giraudier S, Ogier de Baulny H. Erratum to: Isolated remethylation disorders: do our treatments benefit patients? <i>J Inherit Metab Dis</i>. 2011;34(6):1229.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Smolin LA, Benevenga NJ, and Berlow S, &ldquo;The Use of Betaine for the Treatment of Homocystinuria,&rdquo; <i>J Pediatr</i>, 1981, 99:467-72.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/7264811/pubmed\" target=\"_blank\" id=\"7264811\">7264811</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ucar SK, Koro&#287;lu OA, Berk O, et al. Titration of betaine therapy to optimize therapy in an infant with 5,10-methylenetetrahydrofolate reductase deficiency. <i>Eur J Pediatr</i>. 2010;169(2):241-243.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-pediatric-drug-information/abstract-text/19434424/pubmed\" target=\"_blank\" id=\"19434424\">19434424</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 13041 Version 73.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F140590\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F140591\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1056826\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Neonatal\" href=\"#F13207398\" class=\"outlineLink\">Dosing: Neonatal</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1056822\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F140580\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F140570\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Prescribing and Access Restrictions\" href=\"#F11239625\" class=\"outlineLink\">Prescribing and Access Restrictions</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1056829\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F2613425\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1056828\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F140604\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F140603\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F140584\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F2989268\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13298857\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F6218393\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F140577\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F140587\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F1056825\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F3343058\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Additional Information\" href=\"#F1056832\" class=\"outlineLink\">Additional Information</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F6038539\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/13041|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-drug-information\" class=\"drug drug_general\">Betaine (anhydrous, not equivalent to betaine hydrochloride): Drug information</a></li><li><a href=\"topic.htm?path=betaine-anhydrous-not-equivalent-to-betaine-hydrochloride-patient-drug-information\" class=\"drug drug_patient\">Betaine (anhydrous, not equivalent to betaine hydrochloride): Patient drug information</a></li></ul></div></div>","javascript":null}